AI assistant
Sending…
Ascletis Pharma Inc. — Earnings Release 2001
Apr 23, 2002
50081_rns_2002-04-23_1e8114c4-8538-4418-8644-3cd4b0346de5.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| WORLD HOUSEWARE<00713> - Results Announcement (Summary) World Houseware (Holdings) Limited announced on 23/4/2002: (stock code: 713) Year end date: 31/12/2001 Currency: HK$ Auditors' Report: Neither Review of Interim Report by: N/A (Audited) (Audited) Last Current Corresponding Period Period from 1/1/2001 from 1/1/2000 to 31/12/2001 to 31/12/2000 ('000) ('000) Turnover : 650,583 699,970 Profit/(Loss) from Operations : 46,911 32,879 Finance cost : (8,250) (12,154) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : - - Profit/(Loss) after Tax & MI : 36,868 18,301 % Change over Last Period : +101% EPS/(LPS)-Basic : 5.5 cents 2.7 cents -Diluted : 5.0 cents 2.6 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 36,868 18,301 Final Dividend per Share : 0.5 cent 0.5 cent (Specify if with other options) : N/A (with scrip option) B/C Dates for Final Dividend : 22/5/2002 to 28/5/2002 bdi. Payable Date : 18/6/2002 B/C Dates for Annual General Meeting : 22/5/2002 to 28/5/2002 bdi. Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations in respect of the year 2000 was modified to include an amortisation of goodwill amounted to HK$460,000 to conform with the change of SSAP. 2. EARNINGS PER SHARE The calculations of the basic and diluted earnings per share are as follows: 2001 2000 HK$'000 HK$'000 Earnings for the purpose of calculating basic earnings per share 36,868 18,301 Interest on convertible redeemable note 1,761 1,880 ______ ______ Earnings for the purpose of calculating diluted earnings per share 38,629 20,181 ______ ______ Number of shares 2001 2000 Number of shares for the purpose of calculating basic earnings per share 674,436,322 669,570,479 Potential dilutive shares issuable under the convertible redeemable note 95,835,616 102,426,230 ____________ ___________ Weighted average number of shares for the purpose of calculating diluted earnings per share 770,271,938 771,996,709 ____________ ___________ Basic earnings per share 5.5 cents 2.7 cents ____________ ___________ Diluted earnings per share 5.0 cents 2.6 cents ____________ ___________ The computation of diluted earnings per share does not take into consideration the exercise of the Company's outstanding share options as the exercise price of those options is higher than the market price of the Company's shares throughout the year. |
More from Ascletis Pharma Inc.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 18
Regulatory Filings
2026
Mar 17
